Respiratory Distress Syndrome

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

EMA approval · 2026-03-17
EMA Authorised: Gohibic (vilobelimab) — InflaRx GmbH
The European Medicines Agency authorised Gohibic (vilobelimab) from InflaRx GmbH for use in adults with respiratory distress syndrome and CO…